Cord Blood America CEO Discusses Reasons for New, Large Stem Cell Laboratory

* Reuters is not responsible for the content in this press release.

Thu Jul 30, 2009 5:00am EDT 

SANTA MONICA, Calif. and LAS VEGAS, July 30 /PRNewswire-FirstCall/ -- Cord
Blood America, Inc. (OTC Bulletin Board: CBAI), one of the largest umbilical
cord blood stem cell preservation companies (http://www.cordblood-america.com)
focused on bringing the life saving potential of stem cells to families
nationwide and internationally, said today that Matthew Schissler, founder and
CEO, in an interview with analyst Francis Gaskins, emphasized that the
Company's new stem cell laboratory in Las Vegas will allow it to significantly
diversify its revenue stream.

The entire interview is available at http://www.stoxrox.com/cbai-7-29-09.mp3

Cord Blood America recently announced it is opening a state-of-the-art
laboratory, one of the largest in the U.S., for the storage of multiple stem
cell products, including adipose tissue, peripheral blood stem cells and
umbilical cord blood stem cells.  "The lab will allow Cord Blood to store new
sources of stem cells, greatly increasing our competitive advantage," Mr.
Schissler said in the interview.  "We believe that more and more uses for stem
cells in treating diseases are going to be found, making their storage even
more valuable."

Cord Blood America's CEO also emphasized that the new lab reduces the cost of
storing stem cells for the company and allows it to begin a research and
development program and to seek government and other grants.

About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of
CorCell, which facilitates umbilical cord blood stem cell preservation for
expectant parents and their children. Its mission is to be the most respected
stem cell preservation company in the industry. Collected through a safe and
non-invasive process, cord blood stem cells offer a powerful and potentially
life-saving resource for treating a growing number of ailments, including
cancer, leukemia, blood, and immune disorders. To find out more about Cord
Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at
www.corcell.com. For investor information, visit www.cordblood-america.com.

        CONTACT:
        Paul Knopick
        E & E Communications
        949/707-5365
        pknopick@eandecommunications.com



SOURCE  Cord Blood America, Inc.

Paul Knopick of E & E Communications, +1-949-707-5365,
pknopick@eandecommunications.com, for Cord Blood America, Inc.
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.